Mega Genomics (06667) Releases January 2026 Monthly Return, No Change in Share Capital
Bulletin Express
Feb 02
Mega Genomics Limited (Stock Code: 06667) published its monthly return for January 2026, showing that the authorized share capital remained at 500,000,000 ordinary shares with a par value of US$0.0001 each, totaling US$50,000. The number of issued shares stood at 224,300,200—unchanged from the prior month—and included no treasury shares.
The return also confirmed that Mega Genomics Limited’s public float continued to meet the minimum prescribed threshold of 25%. No share options, warrants, convertibles, or other agreements impacting its share capital were recorded during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.